Notably, the administration of utrophin may offer advantages over large doses of the AAV-mini-dystrophin gene, potentially reducing the risk of immune responses observed in canine models of DMD and GRMD (Golden Retriever model for DMD). Here, DMD is linked to Duchenne muscular dystrophy.